PACLITAXEL
NDC 67457-937, PACLITAXEL, injection, powder, lyophilized, for suspension, from Mylan Institutional LLC.
- Product NDC
- 67457-937
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217877
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-937 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PACLITAXEL100 mg/20mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-937-50 | 67457093750 | 20 mL in 1 VIAL (67457-937-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a1a06de1-d9a4-460a-b87d-5e40305b065cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-937
Use it
Look up 67457-937 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-937 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-937. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.